logo
I Got a $4,500 Full-Body MRI to Catch Hidden Health Risks—Here's What It Found

I Got a $4,500 Full-Body MRI to Catch Hidden Health Risks—Here's What It Found

Yahoo3 days ago
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links."
I've always believed in being proactive about my health, but like most people, I usually only see a doctor when something feels wrong or if I'm overdue for an annual exam. That changed when I learned about the Prenuvo scan—a whole-body MRI designed to detect serious conditions like cancer, aneurysms, and degenerative diseases before symptoms appear. The idea of a non-invasive, radiation-free scan that could potentially catch issues early intrigued me. Still, I was skeptical. It's not a medically necessary procedure, is quite pricey (more on this later), and not widely available. Would it be just another wellness trend wrapped in high-tech marketing, or could it actually be the latest health breakthrough—or better yet, a life-saving health screening?
Prenuvo has gained a lot of attention lately, especially after celebrities like Kim Kardashian and Kris Jenner publicly endorsed it, calling it a 'life-saving machine.' Though I don't have an endless health budget of a Hollywood elite, I was lucky enough to receive a complimentary Enhanced Screening. I'm 27 years old, generally healthy, and have no major concerns aside from some chronic neck pain and degenerative disc disease, of which I've already had imaging and treatment. Still, with a family history of cancer and a growing awareness that symptoms don't always show up until it's too late (I've worked at Prevention for years), the opportunity to really see what's going on inside my body excited me.
Meet the experts: Daniel Durand, M.D., M.B.A., chief medical officer and president of Prenuvo Medical Group; Ken Berry, M.D., family physician and co-author of Common Sense Labs; and Mia Kazanjian, M.D., board-certified radiologist specializing in breast and body imaging
The entire process, from booking the appointment to the scan itself to my post-scan consultation, was overall a positive experience. In this Prenuvo review, I'll walk through what the appointment was like, the cost, what my screening found, what medical experts think of a (non-medically-necessary) whole-body MRI, and ultimately, whether I think it was worth it.
What is a whole-body MRI scan?
An MRI (magnetic resonance imaging) is an imaging technique that 'uses protons, magnets, and radio frequency pulses' to create a detailed picture of the inside of the body, says Mia Kazanjian, M.D., board-certified radiologist specializing in breast and body imaging. 'It has no radiation, unlike CT scans and X-rays.' MRI is typically used on individual parts of the body, like the pelvis or the head, on an as-needed basis. Whole-body MRI, on the other hand, does exactly what it sounds like: It uses the same magnetic resonance imaging technology to take a picture of the whole body, which, at Prenuvo, takes about an hour.
'Typically, imaging is done in a very focused manner based on a specific question that another physician is asking,' says Daniel Durand, M.D., M.B.A., chief medical officer and president of Prenuvo Medical Group. 'What Prenuvo does is digitize the entire body. You can think of Prenuvo as a tech-enabled, direct-to-specialist care model. We're digitizing the human body with the most powerful tool, which is MRI, and then we're having a radiologist do a head-to-toe, on the inside, examination of the patient.'
An important note about the limitations of whole-body MRI: 'Preunvo exists to layer on top of existing screenings. This is in addition to, not a replacement of, and we have always said that,' Dr. Durand explains. 'The idea is that if you have a primary care doctor and you're doing your routine screenings, Prenuvo supercharges all that. Our belief is that whole body MRI, plus existing screenings, offers a level of diagnostic accuracy and reassurance that goes beyond anything that came before.'
Ken Berry, M.D., family physician and co-author of Common Sense Labs, agrees that right now, whole-body MRI doesn't replace guideline-based screening (like colonoscopies or mammograms). 'It's a supplemental tool, not a substitute,' he says. 'Whole-body MRI can detect early cancers, aneurysms, and neurological issues, but it's not always better than traditional screening.' Dr. Berry says if you have a strong family history of cancer, a genetic risk, or a history of serious illness, it may be worth considering, but he's cautious about recommending it for the average healthy adult.
My experience
I underwent the Enhanced Screening, the most thorough evaluation Prenuvo offers. This included a whole-body MRI, which covered the brain, chest, abdomen, pelvis, spine, and major vasculature, free from radiation or contrast; a body composition analysis and advanced brain health assessment (taken during the MRI); and a comprehensive bloodwork panel.
The actual experience of getting the MRI was fairly painless. Before the procedure, I was sent a fairly lengthy survey of my medical history to determine whether it was safe for me to undergo the scan and ascertain any health concerns I may have. I also took Prenuvo up on the offer to take a light sedative before heading in to ease any anxiety or claustrophobia to make the experience more comfortable. Then, I arrived at the Manhattan location ready to sit still in an MRI machine for just about an hour. Surprisingly, that hour went by pretty quickly. They gave me the option to choose a show or movie to watch on Netflix during the scan (I decided on Ginny and Georgia), which helped move things along mentally. Before I knew it, I was heading home, where a nurse from a concierge service employed by Prenuvo later drew my blood for the bloodwork portion.
About two weeks after my scan, Prenuvo reached out to schedule my post-scan consultation with Vikash Modi, M.D., senior medical director of preventative medicine at Prenuvo. My virtual consultation with Dr. Modi lasted about 45 minutes, and he walked me through my scan, all of my bloodwork, my body composition analysis, and brain health assessment. He also answered any questions I had and gave me a few suggestions regarding my health moving forward.
The results
About a week prior to officially receiving my results, I got a call from Dr. Modi to discuss one potentially urgent finding from my bloodwork. My blood panel showed that I had a glucose level of 38, which can be very dangerous. We discussed that this was likely due to fasting all day before the bloodwork (which I had scheduled for 3:00 p.m.), as my A1c (a blood test that measures the average blood glucose from the last two-to-three months) was normal. But I was advised to repeat bloodwork with my primary care physician as a precaution. Dr. Modi then reassured me that there were no other major findings on my scan or my bloodwork, but that we would discuss it further at my official consultation.
Fast forward to that appointment: Dr. Modi thoroughly went over my results, starting with my bloodwork, then my scan, the brain health assessment, and finally body composition analysis.
Thankfully, my bloodwork showed I'm in good health, which was reassuring since the blood panel was very comprehensive. However, as Dr. Berry explains, 'comprehensive' doesn't always mean 'useful.' While it did give me a lot of peace of mind, Dr. Berry says that 'although most doctors don't order enough bloodwork, as I discuss in Common Sense Labs, it is also true that ordering too much labwork creates a new set of problems,' including confusion and the potential for reacting when it may not be medically needed.
My scan, however, did show one moderate finding, four minor findings, and one informational finding. In addition to my virtual consultation with Dr. Modi, I was able to visit the Prenuvo online dashboard, which features an interactive and informative report.
FLAIR hyperintense lesion, right frontal lobe. This sounds scary, but it was actually one of my 'minor findings.' On the Prenuvo app, it was labeled a 'small vessel ischemia,' which is a term describing the changes that occur by disrupting the small blood vessels in the brain, and is often a sign of poor cardiovascular health. However, Dr. Modi reassured me that the online interface is always being updated, and that the patient-facing side doesn't always align perfectly with the clinical interpretation. In my case, it may have been caused by head injuries I sustained during my time as a cheerleader. I had no signs of white matter disease, aneurysm, growths, or masses, and overall, my brain volume was very healthy.
Scoliosis. I knew about this 'minor finding' previously from a recent X-ray. I have 'mild' scoliosis in my lumbar spine.
Spondyloarthropathy of the cervical and thoracic spine. These are two 'minor findings' I was also aware of from previous imaging. Spondyloarthropathy is the medical term for degenerative arthritis. I have long struggled with neck and upper back pain, and have been undergoing treatment (mainly physical therapy) for a few months now. Discussing these findings with Dr. Modi reassured me that I'm doing everything right in my current treatment plan.
Hemorrhagic ovarian cysts. This was my only 'moderate finding;' one that I was not previously aware of. While I'm not experiencing any symptoms due to these benign, fluid-filled ovarian cysts, I'm glad I know about them now in case they ever do rupture or cause any complications. While Dr. Modi didn't officially diagnose me, he suggested these may be a sign of polycystic ovary syndrome (PCOS) due to my semi-irregular menstrual cycle, history of acne, and recent struggle to lose weight. He suggested some supplements I might consider taking and made me aware of the typical treatment and medications doctors usually prescribe, should I ever seek that.
Dense breast tissue. The scan also revealed that I have dense breast tissue, which means I have more glandular tissue (as opposed to fat tissue) in my breasts, which may make it more difficult to screen for breast cancer with a typical mammogram. I was already aware of this, as I have a history of breast cysts, which is why I get regular ultrasounds. I was a little surprised the Prenuvo MRI did not pick these up, but Dr. Modi explained that the threshold for breast cysts at Prenuvo is around five millimeters. So, anything smaller than that (which my cysts likely are) would not be picked up by the MRI. 'It's a see-a-lot test, not a see-everything test,' Dr. Modi said.
Following my bloodwork and MRI scan, Dr. Modi went over my brain health assessment, which measured the volume of every structure within the brain. Thankfully, all of those structures in my brain fell into normal ranges.
Finally, we discussed my body composition analysis, which showed data for total muscle mass, subcutaneous fat, and visceral fat. This test is very useful, says Dr. Berry. 'Knowing visceral fat and muscle mass is much better than just looking at Body Mass Index (BMI),' he explains. (Note: Prevention no longer uses BMI as a measurement of health.) Again, thankfully, Dr. Modi ensured that for the most part, my analysis falls into 'normal' ranges for my age and sex, except that I actually have a bit more muscle mass than average, which is a good thing. This test was really interesting to look at because it included a very detailed analysis of hip and lower body muscle volume, as well as a symmetry analysis. None of this was major, but it did confirm a few things I suspected about the way my body works and moves.
Are whole-body MRIs the future of preventative healthcare?
It's difficult to say. 'The essence of what Prenuvo does, and I think it's poorly understood, is that we don't by ourselves prevent anything. But, we can absolutely help a patient choose their own destiny and pursue the right preventative strategies, because we can show them what's going on in them, as opposed to just general advice,' Dr. Durand explains. However, as Dr. Durand and the Prenuvo website state, there are limitations.
I asked Dr. Berry, an unaffiliated family physician, whether whole-body MRIs can meaningfully replace or reduce the need for standard individualized screenings based on modern-day recommendations. He said, not right now. It doesn't replace guideline-based screening. 'It can't do what a colonoscopy or mammogram does, and it doesn't offer the same level of detail. It's a supplemental tool, not a substitute,' Dr. Berry explained. 'If it could fully replace traditional tests, I'd be on board, but the evidence just isn't there yet.'
Dr. Kazanjian adds that whole-body MRI 'tends to be more effective at detecting lesions in the kidneys, pancreas, lymph nodes, and bones, among some others,' but that the screening's ability to characterize them as benign or malignant may be limited. She adds that whole-body MRI does not effectively screen for some of the most common cancers, including skin cancer, breast cancer, colon cancer, lung cancer, and cervical cancer.
And while there will certainly be 'findings of import on these exams,' including brain aneurysms, evidence of autoimmune diseases, metabolic syndromes, and small cancers, among others, Dr. Kazanjian explains, it's impossible to say whether whole-body MRI truly leads to improved health outcomes or whether those results would be uncovered via traditional screening methods. There's also the aspect of incidental or benign findings, which are clinically insignificant (meaning they cause no harm), but create a type of 'scanxiety,' or anxiety felt by patients pre- and post-scan, Dr. Kazanjian says.
The cost and impact
My Enhanced Screening at the Manhattan location has a cost of $4,500, but it varies based on the exact scan you choose, and sometimes, the location. There are less costly options, like the regular whole-body MRI ($2,500) or the torso-only MRI ($999). Prenuvo also offers its Warriors Program, which offers discounted services to first responders, military members, and veterans.
While some doctors, like Dr. Kazanjian, do recommend whole-body MRI for high-risk individuals (like those with a strong family history of cancer and/or genetic mutations) and for patients with cancers such as multiple myeloma and lymphoma, it is generally not recommended for the general population, she explains. 'I do not think this is cost-effective for the population, particularly given the large percentage of false positives with the necessity for costly follow-ups,' says Dr. Kazanjian. 'I say this even if the initial service were cost-free.'
Dr. Durand also acknowledges that not everybody can afford the Prenuvo model of healthcare today. That's why he says Prenuvo is working every day to harness the powers of artificial intelligence to become more efficient, which will allow them to bring prices down long-term.
In terms of side effects, MRI, including whole-body MRI, is mostly safe. The 'scanxiety' and inconsequential benign findings that Dr. Kazanjian points out are the main downsides. As with any MRI, it's important to tell your doctor and radiologist if you have any metal or electrical implants in your body (such as pacemakers and infusion pumps), as the magnetic field generated by the MRI machine can pose a hazard to patients in these cases. The detailed questionnaire sent over by the Prenuvo team before your appointment covers these in length, and your radiologist will also inquire about any metal in or on your body before your scan.
The bottom line
'These scans have potential and may help in the future, but right now they're best for people with high risk or specific concerns or a lot of disposable income,' Dr. Berry explains. 'For the average person, they often create more questions than answers. Too much testing can lead to fear, cost, and harm, especially when there's no clear benefit. Prevention and early detection are very important, but it has to be reasonable and relevant, not just expensive.'
Reflecting on my experience with the whole-body MRI at Prenuvo, I feel fortunate to have had access to such advanced technology. The scan provided valuable insights into my body's health that I wouldn't have otherwise had. However, while I wouldn't hesitate to recommend it to those who have the resources and are curious about their health, I do believe it's important to approach it with a balanced perspective. From a cost-benefit standpoint, it's not yet a universally essential tool in healthcare, and its value largely depends on individual circumstances and priorities.
'The best advice I can give to the people reading this is the advice I live by and the advice I give my patients. This is the same advice I give my mother—and I love my mother. It's to live a healthy life—keep a healthy weight, eat whole grains and vegetables and lean protein, exercise regularly, sleep seven hours a night, avoid tobacco and alcohol, and get annual checkups, recommended screenings, and vaccines with your doctor,' Dr. Kazanjian says. 'Prevention is the best medicine.'
You Might Also Like
Can Apple Cider Vinegar Lead to Weight Loss?
Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Multiple Chronic Conditions Tied to Poor Prognosis in RA
Multiple Chronic Conditions Tied to Poor Prognosis in RA

Medscape

timean hour ago

  • Medscape

Multiple Chronic Conditions Tied to Poor Prognosis in RA

TOPLINE: In patients with rheumatoid arthritis (RA), the presence of multiple chronic conditions was associated with an increased likelihood of disease flare and reduced odds of achieving remission. METHODOLOGY: Researchers conducted a retrospective, population-based study to investigate how multiple chronic conditions and adverse social determinants of health influence disease activity in patients with RA. They analyzed the data of 659 patients with incident RA diagnosed between January 1999 and December 2014 (median age, 55.3 years; 69.7% women); each participant was required to have complete medical history of at least 1 year. A list of 55 chronic medical conditions was used to identify multimorbidity (two or more conditions) and substantial multimorbidity (five or more conditions); the burden of adverse social determinants of health was assessed using the Area Deprivation Index and Social Vulnerability Index, considering factors such as socioeconomic status, housing quality, and education, among others. Flare was identified as a worsening of disease requiring initiation, change, or escalation of treatment; remission was identified as having no more than one tender or swollen joint and normal inflammatory markers The patients were followed for a median duration of 10.3 years and had a median number of 13 RA-related visits during the follow-up period. TAKEAWAY: Among the participants, 73.3% of patients had multimorbidity and 36.1% had substantial multimorbidity. Patients with multimorbidity had 29% higher odds of an RA-related visit for disease flare and those with substantial multimorbidity had 26% higher odds (P < .05 for both); multimorbidity and substantial multimorbidity were also associated with significantly lower odds of a visit due to remission (odds ratios, 0.66 and 0.67, respectively; P < .05 for both). Each 0.1 increase in the Social Vulnerability Index above 0.3 was associated with 8% lower odds of achieving remission (P < .05). Female sex, current smoking, younger age, and shorter disease duration were associated with higher odds of a flare visit; on the contrary, male sex, never smoking, and longer disease duration were associated with higher odds of a remission visit. Seropositivity showed no significant association with either outcome. IN PRACTICE: 'Multimorbidity shows potential to act as a prognostic factor for RA disease activity and can be readily adapted to real-world clinical settings. Increased attention to multimorbidity would help identify patients at risk of poor disease control, signaling to clinicians to consider more aggressive intervention early on,' the authors of the study wrote. SOURCE: This study was led by Daniel Montes, MD, Mayo Clinic, Rochester, Minnesota. It was published online on August 5, 2025, in RMD Open. LIMITATIONS: This retrospective study relied on diagnostic codes for identifying comorbidities. The use of disease-modifying antirheumatic drugs could not be accounted for. The study population was predominantly White (88%), limiting generalizability. DISCLOSURES: This study was supported by grants from the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and National Institute on Aging. One author reported receiving intellectual property/patents from Girhilet, NLC Health Ventures, and Remission Medical and grant/research support from Pfizer. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

State officials launch 10-year plan to boost supports for growing senior population
State officials launch 10-year plan to boost supports for growing senior population

Yahoo

timean hour ago

  • Yahoo

State officials launch 10-year plan to boost supports for growing senior population

Department of Aging Secretary Carmel Roques says that new 10-year road map to boost senior-focused initiatives in the state is "designed to ensure that Marylanders can age with dignity." (Photo by William J. Ford/Maryland Matters). Across the United States, health officials are bracing for the rising population of senior citizens expected in the next couple years, as 'Baby Boomers' continue to age into retirement and will likely need additional supports to secure affordable housing options, health care and other resources. In what it calls the 'Graying of America,' the U.S. Census Bureau estimates that by 2034, the number of people aged 65+ and older will outnumber children aged 18 and younger for the first time in the United States' history. Maryland officials are trying to get ahead of the problem, announcing a 10-year plan called the Longevity Ready Maryland initiative to boost supports for older residents in the state in coming years. In a briefing about the plan Wednesday, Secretary Carmel Roques with the Maryland Department of Aging said that Longevity Ready Maryland is 'designed to ensure that Marylanders can age with dignity, purpose and independence' by promoting collaboration between government agencies, philanthropic efforts and the private sector. 'This is the only way we can truly begin to meet the challenges and also to really be able to realize the potential and benefits of an older and aging population,' Roques said, noting that there are over 1.4 million people over the age of 60 in Maryland as of now. According to state estimates, about 1 in 4 Marylanders will be 60-years-old or older by 2030. By 2045, an estimated 315,000 people in the state will be age 85 or older. 'We must strengthen supports for people who are aging now and for people who are already older and their care givers,' Roques said. In a written statement, Gov. Wes Moore (D) said that the launch of Longevity Ready Maryland will work to support older Marylanders at a time when the Trump Administration has been cutting back on spending for programs that they rely on, such as Medicaid and food assistance. 'Maryland is stepping forward with urgency and a clear plan to put the well-being of older Marylanders front and center,' Moore said in the statement. 'By coordinating action across state agencies, community organizations, and the private sector, Longevity Ready Maryland takes a resilient approach to aging and makes efficient use of every resource as federal support becomes less certain.' The Longevity Ready Maryland roadmap has been under development for almost two years, following Moore's executive order issued on Jan. 3, 2024, to create the initiative. The roadmap outlines four overarching goals, each with short-term and long-term policy suggestions to achieve those initiatives: Build inclusive communities that are friendly to senior residents and their needs, Strengthen the caregiver workforce, Invest in health programs so that older people can stay healthier longer, Create more affordable housing opportunities and promote financial planning so seniors can have stable housing option. 'Maryland is at a demographic crossroads,' the executive summary of the plan says. 'Longer lives and declining birth rates have introduced a significant shift in how our current systems will need to function as the growing number of older adults continues to expand.' With the multi-agency, multi-sector collaboration, the Moore administration hopes to aid aging residents with the many challenges that come with old age, such as housing needs, financial challenges and health care services. Danielle Meister, assistant secretary of homeless solutions with the Maryland Department of Housing and Community Development, said that the need for affordable housing options that are suitable for older people is 'one of the big needs' for the senior population. 'We're facing a severe shortage of affordable housing in our state,' she said,' but this need is more acute and significant for older adults.' She said that department data estimates that 130,000 Marylanders 65-years-old and older face a housing cost burden, meaning they pay more than 30% of their income on rent or a mortgage. 'It makes it really difficult, especially for older adults who are often on restricted incomes, to meet their basic needs,' Meister said. More people aged 65+ face homelessness, state housing officials report The state also needs additional accessible housing so more Marylanders can 'age in place independently' and not have to move into a new living situation when more health needs or disabilities arise. Allison Roenigk Ciborowski, President and CEO of LeadingAge Maryland, said in a written statement Wednesday that said that the 'important — and hardest — work lies ahead.' 'A plan is only as good as how it is implemented and resourced,' she said in the statement. 'We are thrilled to see the full support of LRM by the Governor, and we are eager to continue to work closely with MDOA, state agencies, and legislators to ensure that the goals for coordination and collaboration truly come to life.' Solve the daily Crossword

Pediatric-to-Adult HIV Transition Model Shows Mixed Results
Pediatric-to-Adult HIV Transition Model Shows Mixed Results

Medscape

timean hour ago

  • Medscape

Pediatric-to-Adult HIV Transition Model Shows Mixed Results

TOPLINE: The Adolescent and Young Adult (AYA) Healthcare Transition (HCT) clinic — a pediatric-to-adult HIV care model — achieved a high 1-year retention rate but a suboptimal viral suppression rate despite high engagement in care. Ryan White funding and program adaptability emerged as key strengths, while the region's political climate and HIV stigma remained as major barriers. METHODOLOGY: AYAs with HIV infection transitioning to adult care face challenges such as low retention and poor viral suppression; AYAHCT clinic was designed to address these issues and improve health outcomes in this population. Researchers conducted a mixed-methods analysis to evaluate the design, implementation, and early clinical outcomes of the AYAHCT clinic set up within the Adolescent and Young Adult Health Clinic in the Southeastern US. Quantitative analysis included 18 patients with HIV infection (mean age at first visit, 19.8 years; 78% boys) retrospectively assessed for clinical outcomes including clinic visit attendance, viral suppression, and retention in care. Qualitative analysis included nine semistructured interviews with key stakeholders in pediatric, AYAHCT, and adult HIV clinics to address facilitators of and barriers to clinic implementation. TAKEAWAY: Patients in the AYAHCT clinic averaged 4.4 visits per year, achieved 100% retention in care after 1 year, and had a viral suppression rate of 79.3%. Among the seven patients who transitioned from the AYAHCT clinic to adult care, retention remained high at 85.7%, with viral suppression improved to 96.8%. Key facilitators of clinic implementation included Ryan White funding, strong community connections, positive attitudes among providers and staff, and program adaptability. Major barriers were HIV-related stigma, the region's political climate, clinic workflow challenges, and adverse social determinants of health. IN PRACTICE: 'Our study described an innovative care model to improve AYA retention in HIV care, with future opportunities to improve VL [viral load] suppression,' the authors wrote. SOURCE: This study was led by Nina E. Hill, University of Michigan, Ann Arbor, Michigan. It was published online on July 21, 2025, in AIDS Care. LIMITATIONS: This study was limited by its small sample size, affecting the generalizability of the findings. The HIV care model involving both adolescent medicine and HIV specialists may not have been applicable to all settings. Long-term follow-up after transition to the adult HIV clinic was limited. DISCLOSURES: This study was supported by the Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center. The authors reported having no potential conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store